Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 4

2(33.3%)

N/A

2(33.3%)

Phase 2

1(16.7%)

Phase 3

1(16.7%)

6Total

Phase 4(2)

N/A(2)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT03662022Phase 3Completed

Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar

Role: collaborator

NCT03073317Not ApplicableCompleted

PREPARE, Prematurity Reduction by Pre-eclampsia Care

Role: lead

NCT05873738Completed

Smoking Cessation in a Cohort HIV+ Rio de Janeiro, Brazil.

Role: lead

NCT05087368Phase 2Unknown

Immunogenicity and Safety of Heterologous and Homologous Boosting With ChAdOx1-S and CoronaVac or a Formulation of SCB-2019 (COVID-19)

Role: collaborator

NCT03148483Not ApplicableCompleted

Calcium-vitamin D & Periodontal Therapy for Improving Metabolic and Inflammatory Profile Among Pregnant Women

Role: collaborator

NCT00288600Phase 4Completed

Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease

Role: collaborator

NCT00703950Phase 4Terminated

Sucking Pattern of Preterm Infants Using Cup or Bottle Before Breastfeeding

Role: lead

All 7 trials loaded